Immune disturbances in female genital tuberculosis and latent genital tuberculosis
American Journal of Reproductive Immunology · 2023-02 · 89 (2)
DOI: 10.1111/aji.13632 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 23.12.2022. Verfasst von Jai Bhagwan Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Tuberculosis, Female Genital, Infertility, Female. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 136 Literaturangaben.
Abstract (Originalsprache)
Background
Female genital tuberculosis (FGTB), an important clinical sub‐type of extra‐pulmonary tuberculosis (EPTB) is responsible for about 10% cases of infertility in India. Both FGTB and latent genital tuberculosis (LGTB) can cause infertility through blockage of fallopian tubes and through altered uterine endometrial receptivity.
Aims
This review tries to elucidates the role of various immune factors in FGTB and LGTB. Content Various immune disturbances are observed in FGTB and LGTB like growth factors and cytokines which inhibit implantation and several inflammatory signaling pathways like mitogen activated protein kinase (MAPK), natural killer (NK) cells, nuclear factor kappa‐B (NF‐KB), tumor necrosis factor (TNF), and toll like receptors (TLR) signaling are dysregulated. These altered immune factors and pathways may be detected in the endometrial biopsies at the early stages of disease before permanent damage. Prompt and adequate treatment with the four anti‐tubercular drugs (rifampicin [R], isoniazid [H], pyrazinamide [Z], and ethambutol [E]) can increase pregnancy rates in some of these women. Assisted reproduction especially in‐vitro fertilization and embryo transfer may be required for some women.
Implications
Inflammatory pathways identified from the gene profiling have enabled development of potential biomarkers for early diagnosis of FGTB. Immunomodulation and novel biotechniques like stem cell transplantation, nanoparticles and host directed therapies are being tried in selected patients of FGTB and LGTB with promising results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Paediatrics, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
- Department of Medicine, KU School of Medicine, Wichita, Kansas, USA.
ORCID-Profile: Jai Bhagwan Sharma
Zitieren
APA
Sharma, J. B., Sharma, S., Sharma, E., Dharmendra, S., & Singh, S. (2023). Immune disturbances in female genital tuberculosis and latent genital tuberculosis. American Journal of Reproductive Immunology, 89(2). https://doi.org/10.1111/aji.13632
Vancouver
Sharma JB, Sharma S, Sharma E, Dharmendra S, Singh S. Immune disturbances in female genital tuberculosis and latent genital tuberculosis. American Journal of Reproductive Immunology. 2023;89(2). doi:10.1111/aji.13632
BibTeX
@article{Sharma2023,
author = {Sharma, Jai Bhagwan and Sharma, Sangeeta and Sharma, Eshani and Dharmendra, Sona and Singh, Sheena},
title = {Immune disturbances in female genital tuberculosis and latent genital tuberculosis},
journal = {American Journal of Reproductive Immunology},
year = {2023},
volume = {89},
number = {2},
doi = {10.1111/aji.13632}
}
EUVIMED